Influenza Vaccines - Administration & dosage
Research News and Information

Sunday, November 22, 2009

Update on influenza A (H1N1) 2009 monovalent vaccines.

7 Oct 2009 On September 15, 2009, four influenza vaccine manufacturers received approval from the Food and Drug Administration for use of influenza A (H1N1) 2009 monovalent influenza vaccines in the prevention of influenza caused by the 2009 pandemic influenza ... Read more...

Influenza vaccination coverage among children and adults - United States, 2008-09 influenza season.

7 Oct 2009 Before 2008, the Advisory Committee on Immunization Practices (ACIP) had recommended annual vaccination for influenza for persons aged >or=50 years, 18-49 years at higher risk for influenza complications, and 6 months--4 years. In 2008, ACIP ... Read more...

H1N1 vaccine for prevention of pandemic influenza.

3 Oct 2009 The FDA has licensed 4 new monovalent vaccines for prevention of respiratory illness caused by a new influenza A H1N1 virus that appears to be derived from a swine strain. The 5th vaccine should be licensed soon. All of these vaccines are expected ... Read more...

Latest indexed articles for 'Influenza Vaccines - Administration & dosage'

These are the very latest articles for this heading:

• The H1N1 vaccine plan. 11 Oct 2009
• CMA on the vaccine plan. 11 Oct 2009
• Update on influenza A (H1N1) 2009 monovalent vaccines. 7 Oct 2009
• Influenza vaccination coverage among children and adults - United States, 2008-09 influenza season. 7 Oct 2009
• How to win trust over flu. 6 Oct 2009
• H1N1 vaccine for prevention of pandemic influenza. 3 Oct 2009
• Influenza vaccination coverage among children aged 6-23 months - United States, 2007-08 influenza season. 30 Sep 2009
• Influenza vaccination coverage among children aged 6 months--18 years - eight immunization information system sentinel sites, United States, 2008-09 influenza season. 30 Sep 2009
• A cell culture (Vero)-derived H5N1 whole-virus vaccine induces cross-reactive memory responses. 29 Sep 2009
• [Physicians as key communicators of the influenza vaccination for the elderly, patients with chronic conditions, and health care workers. Results of a nationwide survey in the context of the national influenza vaccination campaign] 29 Sep 2009
• Children are likely to need two doses of swine flu vaccine. 23 Sep 2009
• Flu pandemic prompts other vaccination delays. 19 Sep 2009
• Seasonal trivalent influenza vaccine for 2009-2010. 19 Sep 2009
• Swine flu outbreak. China first to vaccinate against novel H1N1 virus. 16 Sep 2009
• CDC names H1N1 vaccine priority groups. 14 Sep 2009
• Public health. A race against time to vaccinate against novel H1N1 virus. 9 Sep 2009
• Receipt of influenza vaccine during pregnancy among women with live births--Georgia and Rhode Island, 2004-2007. 9 Sep 2009
• [Mysteries not resolved by A(H1N1)] 7 Sep 2009
• Australia's influenza containment plan and the swine flu epidemic in Victoria. 5 Sep 2009
• The community's attitude towards swine flu and pandemic influenza. 5 Sep 2009

See a longer list of these articles.

Technical information about 'Influenza Vaccines'

Definition: Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed or attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The vaccine is usually bivalent or trivalent, containing one or two INFLUENZAVIRUS A strains and one INFLUENZAVIRUS B strain.

Registry Number: 0

Descriptor UI: D007252

Alternative terms: Influenza Vaccines; Vaccines, Influenza; Influenzavirus Vaccines; Vaccines, Influenzavirus; Influenza Virus Vaccines; Vaccines, Influenza Virus; Virus Vaccines, Influenza; Flu Vaccines; Vaccines, Flu; Influenza Vaccine; Vaccine, Influenza; Trivalent Live Attenuated Influenza Vaccine; LAIV vaccine; vaccine, LAIV; FluMist; MedImmune Vaccines Brand of Trivalent Live Attenuated Influenza Vaccine; CAIV-T vaccine;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D20.215.894.899.302;

History Note: 2005 (1963)

Technical Notes: coordinate IM with specific influenza virus or virus subtype /immunol (IM); SCR records for several specific influenza vaccines are also available; not for Haemophilus influenzae vaccines ( = HAEMOPHILUS VACCINES)